Literature DB >> 29102675

RNA-Seq revealed ATF3-regulated inflammation induced by silica.

Judy Y W Chan1, Joseph C C Tsui2, Patrick T W Law3, Winnie K W So4, Doris Y P Leung4, Michael M K Sham5, Stephen K W Tsui6, Carmen W H Chan7.   

Abstract

BACKGROUND: Millions of workers are exposed to dust containing silica. Chronic and over-exposure to silica will lead to silicosis, which is an irreversible and sometimes fatal lung disease. The disordered physiological processes of silicosis consist of accumulation of silica particles in the alveoli of the lung. Then, the ingestion of the silica particles by macrophages was followed by an inflammatory response. Up till now, the chest radiographs remain the key tool in diagnosing and assessing the extent of silicosis. However, concerns exist regarding the sensitivity and specificity of the technique. Therefore, there is still a need to develop a biomarker for silicosis for early detection of silicosis.
METHOD: In this study, RNA-Seq was applied to detect the gene expression changes when silica was exposed to macrophages at different time intervals. RNA-Seq provides a broader dynamic range, increased specificity and sensitivity, and easier detection of rare and low-abundance transcripts. Bioinformatics tools such as the Database for Annotation, Visualization and Integrated Discovery (DAVID) and Gene Functional Classification Tool and Search Tool for the Retrieval of Interacting Genes (STRING) were applied for data analysis. Quantitative PCR was used to validate the results.
RESULTS: Our results showed that regulation of transcription factors was the dominant activated pathway in early exposure of silica to macrophages, followed by inflammatory responses which were the main mechanisms in silicosis. One of the findings was the upregulation of activating transcription factor 3 (ATF3) during silica exposure. When ATF3 expression was inhibited by siRNA, the production of cytokines IL-1β, IL-6 and TNF was further increased.
CONCLUSION: This indicated that ATF3 may be a potential early diagnostic biomarker for silicosis and ATF3 acts as a repressor in inflammatory responses induced by silica.
Copyright © 2017 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  ATF3; Inflammation; RNA-Seq; Silica; Silicosis

Mesh:

Substances:

Year:  2017        PMID: 29102675     DOI: 10.1016/j.tox.2017.11.001

Source DB:  PubMed          Journal:  Toxicology        ISSN: 0300-483X            Impact factor:   4.221


  5 in total

1.  ASC-J9® suppresses prostate cancer cell proliferation and invasion via altering the ATF3-PTK2 signaling.

Authors:  Hao Tian; Fu-Ju Chou; Jing Tian; Yong Zhang; Bosen You; Chi-Ping Huang; Shuyuan Yeh; Yuanjie Niu; Chawnshang Chang
Journal:  J Exp Clin Cancer Res       Date:  2021-01-04

2.  Multi-omics study of silicosis reveals the potential therapeutic targets PGD2 and TXA2.

Authors:  Junling Pang; Xianmei Qi; Ya Luo; Xiaona Li; Ting Shu; Baicun Li; Meiyue Song; Ying Liu; Dong Wei; Jingyu Chen; Jing Wang; Chen Wang
Journal:  Theranostics       Date:  2021-01-01       Impact factor: 11.556

Review 3.  Pulmonary Toxicity of Silica Linked to Its Micro- or Nanometric Particle Size and Crystal Structure: A Review.

Authors:  Vanessa Marques Da Silva; Manon Benjdir; Pierrick Montagne; Jean-Claude Pairon; Sophie Lanone; Pascal Andujar
Journal:  Nanomaterials (Basel)       Date:  2022-07-13       Impact factor: 5.719

4.  Comparative Transcriptome Analyses Reveal a Transcriptional Landscape of Human Silicosis Lungs and Provide Potential Strategies for Silicosis Treatment.

Authors:  Junling Pang; Ya Luo; Dong Wei; Zhujie Cao; Xianmei Qi; Meiyue Song; Ying Liu; Zhaoguo Li; Jin Zhang; Baicun Li; Jingyu Chen; Jing Wang; Chen Wang
Journal:  Front Genet       Date:  2021-06-03       Impact factor: 4.599

5.  Regulation of TLR4 in silica-induced inflammation: An underlying mechanism of silicosis.

Authors:  Judy Yuet Wa Chan; Joseph Chi Ching Tsui; Patrick Tik Wan Law; Winnie Kwok Wei So; Doris Yin Ping Leung; Michael Mau Kwong Sham; Stephen Kwok Wing Tsui; Carmen Wing Han Chan
Journal:  Int J Med Sci       Date:  2018-06-14       Impact factor: 3.738

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.